The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
March 18th 2024
In an announcement by Aquestive Therapeutics, these new findings demonstrated the potential of this orally-administered epinephrine treatment.
Community Practice Connections™: Preparing for an Expanded Armamentarium for Food Allergy
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Childhood Obesity and Risk of Allergy or Asthma
A recent study looked at the relationship between obesity and a child's risk of developing allergies or an asthmatic condition. Looking at what the authors perceived to be a growing trend of not only an increase in the number obese children but those suffering from new or worsening allergies the authors said they were looking for a link which could help treat the pediatric patients.
Study: Immune System Protein Has Regulatory Function in Brain
Immune system proteins play a role in regulating the number of neural synapses, a research team from Princeton University and the University of California-San Diego report. The finding could mean that one of these proteins-known as major histocompatibility complex class I (MHCI) could play a significant role in Alzheimer's disease, type II diabetes and autism.
New research provides some of the first concrete support for a treatment guideline that has long been recommended on grounds of common sense alone: Patients who suffer severe allergic reactions such as anaphylaxis should follow up on their emergency room care by seeing an allergist or immunologist.
FDA Oks Label Change for MS drug
The US Food and Drug Administration (FDA) approved Genzyme's application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
A third patient has been diagnosed with Ebola in Dallas, TX. The unidentified woman is the second Texas Presbyterian Health worker to get the disease after caring for deceased Ebola victim Thomas Eric Duncan, local officials said in an early morning news conference. The patient, like nurse Nina Pham, is in isolation at Texas Presbyterian Health. The US Centers for Disease Control and Prevention (CDC) along with Texas health officials are monitoring 75 people who had contact with Duncan, the visitor from Liberia who died of the disease Oct. 8.
No Absence of Key Antiviral Mechanism in Asthmatics
October 1st 2014Because a key antiviral defense mechanism is present in asthmatics, another defect in their immune system must explain their difficulty combating respiratory viruses, according to researchers from Washington University in St. Louis.
Questions Abound Regarding the Handling of the Case of the Texas Man Diagnosed with Ebola
Reports indicate the patient presented with Ebola-like symptoms at a local emergency room and told staff he had recently traveled to Africa. If so, why wasn't CDC protocol followed, and why was the man sent home?
New Findings on How Glatiramer Acetate Works for Multiple Sclerosis
Patients with the relapsing-remitting form of multiple sclerosis have shown improvement with glatiramer acetate. Although it is unclear exactly how the drug works, recently published research has shed light on the ways in which glatiramer acetate affects B cells.
Many Schools Not Prepared to Handle Emergencies Involving Children with Food Allergies and Asthma
New research from Northwestern University has found that schools are woefully unprepared to deal with anaphylaxis and other life-threatening emergencies stemming from student allergies.
So What's Really Building up Inflammatory Bowel Disease?
Monitoring patients' own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.
EAACI Calls for Revamped Research Agenda for Food Allergy
Recent efforts to overhaul standards of care for both food allergies in general and anaphylaxis in particular led expert panels from the European Academy of Allergy and Clinical Immunology to a shocking conclusion.
Research on Milk Allergens Could Benefit Greater Food Allergy Problem
Researchers from the Ecole Polytechnique Federale de Lausanne report having developed a fast and accurate method for determining exactly which milk proteins produce allergic reactions in specific patients.